Montelukast Induces Depressive‐Like Behaviour in ICR Young Mice Through Oxidative Stress and Inflammatory Response
Basic & Clinical Pharmacology & Toxicology · 2025
DOI: 10.1111/bcpt.70033 ↗At a glance
Journal article in Basic & Clinical Pharmacology & Toxicology, 2025. Written by Shalawate Ayijiang and 8 co-authors. Institution: Department of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. Major MEDLINE topics: Oxidative Stress, Cyclopropanes, Sulfides, Quinolines. Cited 1 times so far (Crossref); 37 references. Funded by: National Natural Science Foundation of China.
Abstract (original language)
Background
In response to the US Food and Drug Administration's black box warning highlighting the neuropsychiatric risks associated with montelukast, the mechanisms underlying these psychiatric adverse effects, particularly depression in paediatric populations, have remained poorly understood.
Methods
To address this, we examined whether montelukast induces depression‐like behaviours in an animal model and investigated the potential mechanisms. Young ICR mice were administered montelukast continuously for 28 days, and depression‐like behaviours were assessed using the open field test (OFT), tail suspension test (TST), and forced swim test (FST). Oxidative stress and inflammatory markers were analysed via RT‐qPCR, biochemical assays and western blot.
Results
Our results revealed that 24 h post‐montelukast administration, cysteinyl leukotriene receptor 1 and malondialdehyde (MDA) levels were significantly upregulated in the hippocampus, while glutathione (GSH), glutathione peroxidase 4 (GPx4), superoxide dismutase 2 (SOD2) and catalase (CAT) levels were downregulated. After 28 days of treatment, MDA levels remained elevated, and GSH, GPx4, SOD2 and CAT levels were further reduced. Additionally, hippocampal interleukin‐1β and serum corticosterone levels were increased, whereas hippocampal glucocorticoid receptor expression was decreased.
Conclusions
These findings collectively demonstrate that montelukast induces depression‐like behaviours in young ICR mice through mechanisms involving enhanced oxidative stress and inflammatory responses.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
- Department of Pharmacy, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
ORCID profiles: Zengliang Jin
Funding
- National Natural Science Foundation of China
Cite
APA
Ayijiang, S., Tiliwaerde, M., Yang, Y., Li, Y., Gao, H., Jia, J., Wang, S., Liu, Q., & Jin, Z. (2025). Montelukast Induces Depressive‐Like Behaviour in ICR Young Mice Through Oxidative Stress and Inflammatory Response. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70033
Vancouver
Ayijiang S, Tiliwaerde M, Yang Y, Li Y, Gao H, Jia J, et al. Montelukast Induces Depressive‐Like Behaviour in ICR Young Mice Through Oxidative Stress and Inflammatory Response. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70033
BibTeX
@article{Ayijiang2025,
author = {Ayijiang, Shalawate and Tiliwaerde, Murezati and Yang, Yaqi and Li, Yanlin and Gao, Huan and Jia, Jingyi and Wang, Shen and Liu, Qi and Jin, Zengliang},
title = {Montelukast Induces Depressive‐Like Behaviour in ICR Young Mice Through Oxidative Stress and Inflammatory Response},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
doi = {10.1111/bcpt.70033}
}
EUVIMED